| Primary |
| Surgery |
43.5% |
| Benign Prostatic Hyperplasia |
19.6% |
| Hiv Infection |
6.5% |
| Bacteraemia |
2.2% |
| Bronchopneumonia |
2.2% |
| Depression |
2.2% |
| Epilepsy |
2.2% |
| Essential Hypertension |
2.2% |
| Gastritis |
2.2% |
| Hypertension |
2.2% |
| Hypertonic Bladder |
2.2% |
| Pain |
2.2% |
| Polymyalgia Rheumatica |
2.2% |
| Prostate Cancer |
2.2% |
| Prostatic Disorder |
2.2% |
| Pyrexia |
2.2% |
| Residual Urine |
2.2% |
|
| Atrial Fibrillation |
13.3% |
| Mydriasis |
13.3% |
| Oesophageal Spasm |
13.3% |
| Rash Erythematous |
13.3% |
| Fall |
6.7% |
| Multi-organ Failure |
6.7% |
| Penis Deviation |
6.7% |
| Pruritus |
6.7% |
| Syncope |
6.7% |
| Therapeutic Response Decreased |
6.7% |
| Thrombocytopenia |
6.7% |
|
| Secondary |
| Hiv Infection |
32.3% |
| Drug Use For Unknown Indication |
23.1% |
| Pain |
10.8% |
| Epilepsy |
9.2% |
| Gastritis |
9.2% |
| Prostatic Disorder |
7.7% |
| Helicobacter Infection |
4.6% |
| Benign Prostatic Hyperplasia |
3.1% |
|
| Rash Erythematous |
60.0% |
| Toxic Skin Eruption |
20.0% |
| Erythema |
10.0% |
| Spinal Compression Fracture |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.4% |
| Hypertension |
12.2% |
| Benign Prostatic Hyperplasia |
9.3% |
| Atrial Fibrillation |
6.1% |
| Parkinson's Disease |
5.5% |
| Prophylaxis |
5.5% |
| Trigeminal Neuralgia |
5.2% |
| Diabetes Mellitus |
4.9% |
| Drug Use For Unknown Indication |
4.1% |
| Essential Hypertension |
4.1% |
| Myocardial Ischaemia |
3.8% |
| Pain |
3.5% |
| Atrial Flutter |
2.9% |
| Constipation |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Helicobacter Gastritis |
2.6% |
| Mantle Cell Lymphoma |
2.6% |
| Non-small Cell Lung Cancer |
2.6% |
| Pain In Extremity |
2.0% |
| Depression |
1.7% |
|
| Vision Blurred |
11.1% |
| Tremor |
8.3% |
| Renal Failure Chronic |
6.9% |
| Cytomegalovirus Infection |
5.6% |
| Hypoglycaemic Coma |
5.6% |
| Somnolence |
5.6% |
| Vomiting |
5.6% |
| Weight Decreased |
5.6% |
| Aplasia Pure Red Cell |
4.2% |
| Bronchopneumonia |
4.2% |
| Cerebral Ischaemia |
4.2% |
| Erythema |
4.2% |
| Muscle Atrophy |
4.2% |
| Muscular Weakness |
4.2% |
| Osteoarthritis |
4.2% |
| Pneumonia |
4.2% |
| Renal Failure Acute |
4.2% |
| Cardiac Failure |
2.8% |
| Drug Abuse |
2.8% |
| Gamma-glutamyltransferase Increased |
2.8% |
|
